Your browser doesn't support javascript.
loading
Identification of a Novel MPRIP-ROS1 Fusion and Clinical Efficacy of Crizotinib in an Advanced Lung Adenocarcinoma Patient: A Case Report.
Shu, Yun; Li, Hui; Shang, Hongjuan; Chen, Jun; Su, Xiaoxing; Le, Wei; Lei, Yan; Tao, Liming; Zou, Cailiang; Wu, Wendy.
Afiliação
  • Shu Y; Department of Medical Oncology, Third People's Hospital of Jiujiang City, Jiujiang 332000, People's Republic of China.
  • Li H; Berry Oncology Corporation, Fuzhou 350200, People's Republic of China.
  • Shang H; Department of Medical Oncology, Third People's Hospital of Jiujiang City, Jiujiang 332000, People's Republic of China.
  • Chen J; Department of Medical Oncology, Third People's Hospital of Jiujiang City, Jiujiang 332000, People's Republic of China.
  • Su X; Berry Oncology Corporation, Fuzhou 350200, People's Republic of China.
  • Le W; Department of Medical Oncology, Third People's Hospital of Jiujiang City, Jiujiang 332000, People's Republic of China.
  • Lei Y; Berry Oncology Corporation, Fuzhou 350200, People's Republic of China.
  • Tao L; Department of Medical Oncology, Third People's Hospital of Jiujiang City, Jiujiang 332000, People's Republic of China.
  • Zou C; Department of Medical Oncology, Third People's Hospital of Jiujiang City, Jiujiang 332000, People's Republic of China.
  • Wu W; Berry Oncology Corporation, Fuzhou 350200, People's Republic of China.
Onco Targets Ther ; 13: 10387-10391, 2020.
Article em En | MEDLINE | ID: mdl-33116618

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article